Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Farmers Insurance
Dow
Queensland Health
AstraZeneca
Cipla
Medtronic
Fish and Richardson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017830

« Back to Dashboard

NDA 017830 describes LODOSYN, which is a drug marketed by Aton and is included in one NDA. It is available from four suppliers. Additional details are available on the LODOSYN profile page.

The generic ingredient in LODOSYN is carbidopa. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the carbidopa profile page.
Summary for 017830
Tradename:LODOSYN
Applicant:Aton
Ingredient:carbidopa
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017830
Suppliers and Packaging for NDA: 017830
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LODOSYN carbidopa TABLET;ORAL 017830 NDA KAISER FOUNDATION HOSPITALS 0179-0125 N 0179-0125-70
LODOSYN carbidopa TABLET;ORAL 017830 NDA AUTHORIZED GENERIC KAISER FOUNDATION HOSPITALS 0179-0226 N 0179-0226-70

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 017830

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
AstraZeneca
Cerilliant
McKinsey
Cantor Fitzgerald
Fuji
Daiichi Sankyo
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.